Recordkeeping fees per participant
not reported
Not reported on this filing.
Employers › Akebia Therapeutics
Akebia Therapeutics 401(k)
- AKBA Nasdaq
- Health care and social assistance
- Cambridge, MA
- EIN 20-8756903
- 1 plan with Schedule H financials
- Plan year 2024
- Akebia Therapeutics, Inc.
Administrative expenses excluding investment management, per participant · Akebia Therapeutics 401(k) Plan · plan year 2024
$514.49
Higher than 97% of the 24,371 plans $10 to 50M that report it.
Source
= $205,797 / 400
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250515133957NAL0014796419001, received 2025-05-15
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250515133957NAL0014796419001, received 2025-05-15
Percentiles compare this plan with the Schedule H plans $10 to 50M in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-05-15.
Cost and contributions
Administrative expenses per participant
$514.49
Higher than 93% of the 25,098 plans $10 to 50M that report it.
Source
= $205,797 / 400
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250515133957NAL0014796419001, received 2025-05-15
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250515133957NAL0014796419001, received 2025-05-15
Administrative expenses as a share of assets
0.481%
Higher than 80% of the 25,132 plans $10 to 50M that report it.
Source
= $205,797 / $42,759,367
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250515133957NAL0014796419001, received 2025-05-15
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250515133957NAL0014796419001, received 2025-05-15
Employer contributions per participant
$4,312
Higher than 87% of the 24,050 plans $10 to 50M that report it.
Source
= $1,724,730 / 400
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250515133957NAL0014796419001, received 2025-05-15
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250515133957NAL0014796419001, received 2025-05-15
Employer share of total contributions
28.4%
Higher than 52% of the 24,084 plans $10 to 50M that report it.
Source
= $1,724,730 / $6,062,432
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250515133957NAL0014796419001, received 2025-05-15
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250515133957NAL0014796419001, received 2025-05-15
Plan terms, as stated in Akebia Therapeutics, Inc.'s SEC filings
Plan terms are described in Akebia Therapeutics, Inc.'s SEC filings: Form 10-K filed 2026-02-26. No term could be quoted from them with the required precision.
Plan features
2E profit-sharing · 2F ERISA 404(c) plan · 2G fully participant-directed · 2J 401(k) feature · 2K 401(m) arrangement · 2S pre-approved plan document · 2T default investment (QDIA) · 3D IRS pre-approved plan · 3H controlled-group sponsor · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20250515133957NAL0014796419001, received 2025-05-15
Full record, Akebia Therapeutics 401(k) Plan
| Field | Value | Source |
|---|---|---|
| Plan sponsor | AKEBIA THERAPEUTICS, INC. | Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Plan name | AKEBIA THERAPEUTICS 401(K) PLAN | Form 5500, line 1a; PLAN_NAME pos 16; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Sponsor EIN / plan number | 20-8756903 / 001 | Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Plan type | single-employer | Form 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Sponsor location | CAMBRIDGE, MA | Form 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Industry (business code) | 621340, Health care and social assistance | Form 5500, line 2d; BUSINESS_CODE pos 46; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Plan year | 2024-01-01 to 2024-12-31 | Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Filing received | 2025-05-15 | Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Final filing | no | Form 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Amended filing | no | Form 5500, Part I line B; AMENDED_IND pos 7; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Participants, beginning of year | 417 | Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Active participants | 181 | Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Participants, end of year | 407 | Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Participants with an account balance | 400 | Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Total assets, beginning of year | $39,344,235 | Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Total assets, end of year | $42,759,367 | Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Net assets, end of year | $42,759,367 | Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Total income | $11,437,236 | Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Net income | $3,415,132 | Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Employer contributions | $1,724,730 | Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Participant contributions | $3,266,785 | Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Other contributions (incl. rollovers) | $1,070,917 | Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Total contributions | $6,062,432 | Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Benefit payments | $7,816,307 | Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Total expenses (incl. benefit payments) | $8,022,104 | Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Total administrative expenses | $205,797 | Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Administrative expenses excluding investment management | $205,797 | derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Held in mutual funds | $42,759,367 | Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20250515133957NAL0014796419001, received 2025-05-15 |
| Independent auditor | CARON & BLETZER | Schedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20250515133957NAL0014796419001, received 2025-05-15 |
Position = column in the DOL layout for form year 2024. Filing 20250515133957NAL0014796419001, received 2025-05-15.
Service providers paid directly by the plan
| Provider | Relationship | Service codes | Direct compensation | Indirect |
|---|---|---|---|---|
| EMPOWER ADVISORY GROUP, LLC | INVESTMENT MGMT | 28 Investment management | $98,245 | no |
| SECURITIES AMERICA ADVISORS INC | INVESTMENT ADVISOR | 27 Investment advisory (plan) | $23,872 | no |
| EMPOWER ANNUITY INSURANCE COMPANY Orecordkeeper | RECORDKEEPER | 64 Recordkeeping fees | $0 | yes |
Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20250515133957NAL0014796419001, received 2025-05-15.
What changed since the 2023 plan year
| Figure | 2023 | 2024 | Change |
|---|---|---|---|
| Total assets | $39,344,235 | $42,759,367 | 8.7% |
| Participants with a balance | 417 | 400 | -4.1% |
| Administrative expenses | $155,344 | $205,797 | 32.5% |
| Recordkeeping fees per participant | not reported | not reported | |
| Employer contributions | $1,737,460 | $1,724,730 | -0.7% |
Prior filing 20240723173033NAL0011782257001, received 2024-07-23; the plan years are contiguous.
Alerts, claims and corrections
Sponsor name as filed: AKEBIA THERAPEUTICS, INC.; SEC registrant: Akebia Therapeutics, Inc. (CIK 1517022, matched by EIN; display name from the Form 10-K cover).